Beschreibung:
Alentis Therapeutics, the Claudin -1 Company, is on a mission to treat cancer and reverse fibrosis. To this end, we are rapidly advancing a clinical pipeline of anti -Claudin -1 monoclonal antibodies. Our team is committed to unlocking the broad potential of our therapeutic target Claudinmehr erfahren